• Mashup Score: 0

    Objective This study aimed to compare the safety and efficacy of third-generation P2Y12 inhibitors versus clopidogrel in combination with oral anticoagulation (OAC) with or without aspirin in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI). Methods We performed a systematic review including both prospective and retrospective studies that compared dual…

    Tweet Tweets with this article
    • Which P2Y12 inhibitor should be used with #OAC when treatment for #stroke risk reduction is needed in #AFib? In our meta-analysis- the data would indicate that clopidogrel is likely best. @Heart_BMJ @GianShaun @tinolupercioMD @UCSDHealth #EPeeps https://t.co/tVQyae3VKJ https://t.co/2koXW7isUW https://t.co/QlouoTvzmU